Yes, scientific momentum continues to build with apabetalone.

But I believe apabetalone is only the tip of the iceburg. They have 1500 compounds. More importantly they have the scaffolds that produce these compounds and they understand the chemistry of the scaffolds. If you think of it as a car factory that has a production line of various equipment to assemble cars and they are stuck to limits that this equipment can range or innovate.

Resverlogix and Zenith seem to have discovered "a powerful production line" and in the case of apabetalone a very specific focus on BRD4 that has at least 6 positive impacts on various systems.

I do not know if their production line can be shifted (or why it would need to shft) but what I sense is that their knowledge base is very deep. Continued success with apabetalone could allow for further exploration of various alterations on these scaffolds.

GLTA

Toinv